-
South Korea's 'dismal' World Cup ends in group phase
-
England top group to set up DR Congo World Cup clash, Portugal held
-
Colombia and Portugal through to World Cup last 32 after thrilling draw
-
England moving on at World Cup but questions linger
-
Wissa sends DR Congo into World Cup last 32 clash with England
-
Venezuela quakes kill 1,400 as time running out to find survivors
-
A painful wait by a pile of rubble in quake-hit Venezuela
-
Australia World Cup goalkeeper Patrick Beach has beach named after him
-
Tuchel delighted to have Bellingham in 'sweet spot' for England at World Cup
-
Take brutally hot weather seriously, heatstroke survivor warns
-
Bellingham says 'job done' but England must improve at World Cup
-
Australia boosts shark-spotting drone coverage at Sydney beaches
-
Trump threatens to annihilate Iran after new exchange of attacks
-
Scotland boss Clarke resigns after World Cup exit confirmed
-
Scotland boss Clarke resigns after World Cup exit confirmed: official
-
Kane, Bellingham on target as England win World Cup group
-
Kane, Bellingham on target as England clinch top spot
-
Croatia battle past Ghana to sew up World Cup Last 32 spot
-
Bellingham, Kane score as England beat Panama to reach World Cup last 32
-
US, Iran clash, putting fragile deal under growing strain
-
Canada's Davies 'available' for historic knockout clash
-
Ryu takes one-shot lead over Henderson at Women's PGA Championship
-
Hovland seizes one-shot PGA Travelers lead over Scheffler
-
Jangoo and Chase put West Indies in control against Sri Lanka
-
Mauvaka double inspires Toulouse to fourth-straight Top 14 in storm-impacted final
-
World Cup star Gakpo requests privacy after death of unborn son
-
Solidarity, sadness among Venezuelans made destitute by quake
-
Aid planes landing at partially reopened Venezuela airport after quakes
-
Iran says US violated peace deal as both sides attack
-
Spain's Williams hits out at Uruguay over World Cup injury
-
'We need help': Venezuelans furious at slow official response to quakes
-
World's largest particle smasher halts for upgrade to boost hunt for dark matter
-
Venus Williams relishes 'very special' Wimbledon reunion with sister Serena
-
Ex-Olympic medallist Canderloro elected French Ice Sports chief
-
Ravindra leads New Zealand rally in England finale after Archer's double strike
-
Prince Harry and family to stay at royal residences on UK visit
-
Wimbledon 'towel thief' Swiatek back on the trophy hunt
-
'Why not?': Cape Verde eye seismic World Cup shock against Argentina
-
Venezuela earthquake deaths near 1,000, with millions more in need
-
Russell snatches controversial pole in Austria after Verstappen crash
-
French Open champs head to Wimbledon wrestling with new-found status
-
Davidovich Fokina wins in Mallorca for first ATP title
-
Budapest Pride marchers push for equality after reversed ban
-
Sabalenka urges Grand Slams to 'get it done' in prize money boycott row
-
Russell snatches pole, Antonelli fourth for Austria GP grid
-
Russell snatches pole as Verstappen, Antonelli fourth for Austria GP grid
-
Broos smiles and snarls before South Africa's historic World Cup match
-
Smith and supersub Foulkes strike for New Zealand in England finale
-
Newborn baby rescued from rubble of Venezuela quake
-
Supersub Foulkes strike for New Zealand in England finale
Todd H. Lanman to Present First Full U.S. IDE Trial Results for FDA-Approved Synergy Disc(R) at ISASS 2026
Beverly Hills spine surgeon and principal investigator will present pooled clinical outcomes following recent FDA approval of motion-preserving cervical disc technology
BEVERLY HILLS, CA / ACCESS Newswire / April 2, 2026 / Following the recent FDA Premarket Approval (PMA) of the Synergy Disc®, Todd H. Lanman, MD, a pioneer in motion-preserving spine surgery, will present the first full results from the U.S. Investigational Device Exemption (IDE) clinical trial at the International Society for the Advancement of Spine Surgery (ISASS) 2026 Annual Conference in Miami Beach, April 9-11. Dr. Lanman served as a principal investigator in the multicenter U.S. IDE study evaluating the motion-preserving cervical artificial disc, developed by Synergy Spine Solutions, for the treatment of single-level degenerative disc disease from C3-C7.

The Synergy Disc received FDA approval after demonstrating superiority to anterior cervical discectomy and fusion (ACDF) on the study's primary endpoint of composite clinical success at 24 months. In the IDE trial, the device achieved an 87.1% composite clinical success rate, significantly higher than the fusion control group.
Additional key findings included:
91.7% of patients achieved clinically meaningful improvement on the Neck Disability Index at two years compared with 75.2% in the fusion group
Lower mean neck pain scores in the Synergy Disc group (15.6 vs. 30.2 in the fusion cohort)
Lower worst arm pain scores (15.0 vs. 32.2)
Improved segmental alignment, with disc angle increasing from 2.6 degrees pre-operatively to 6.5 degrees at 24 months
Higher patient satisfaction, reported by 84.5% of Synergy Disc patients versus 61.6% of fusion patients
"Artificial disc replacement continues to evolve rapidly, and these IDE results tell a clear story - meaningful reductions in neck and arm pain, better function, and higher patient satisfaction over fusion," said Dr. Lanman. "For patients, that is just not a statistic. That is the ability to return to an active, unrestricted life. That is what motion preservation is ultimately about."
The Synergy device incorporates a lordotic polyethylene core engineered to preserve motion while improving spinal alignment, a design intended to reduce the risk of postoperative kyphosis and maintain physiologic cervical curvature.
Dr. Lanman's presentation at ISASS will provide spine surgeons with a detailed review of the IDE trial methodology, clinical outcomes, and implications for the future of cervical motion-preserving surgery.
The International Society for the Advancement of Spine Surgery (ISASS) Annual Conference is one of the premier scientific meetings dedicated to spine innovation and motion-preservation technologies. The 2026 meeting will bring together leading spine surgeons, researchers, and industry innovators to discuss emerging technologies and advances in spinal care.
About Dr. Todd H. Lanman
Todd Lanman, MD has over three decades of experience as a spinal neurosurgeon and has spent the last 25 years practicing spine surgery in Beverly Hills. In addition to being a world-renowned spinal surgeon, Dr. Lanman has also had 11 spinal surgeries including spinal fusions and artificial disc replacements. Because of these experiences as surgeon and as patient, Dr. Lanman brings a unique perspective to his surgical practice.
About Lanman Spinal Neurosurgery
Lanman Spinal Neurosurgery is committed to improving patients' quality of life by relieving pain and restoring spinal motion. The Beverly Hills practice has been at the leading edge of spine health for the past quarter of a century. Lanman Spinal Neurosurgery has and continues to pioneer artificial disc replacement and fusion revision surgeries to help neck and back pain sufferers live their best lives.
About Synergy Spine Solutions
Synergy Spine Solutions is a medical device company focused on improving the quality of life for patients undergoing spine surgery. The company develops motion-preserving technologies designed to treat degenerative disc disease while supporting the spine's natural curvature. Its flagship product, the FDA-approved Synergy Disc®, features a built-in 6-degree lordotic core designed to not only preserve motion but also improve sagittal alignment.
Media Contact:
Brandi Kamenar
Brandi Kamenar Brand Management
BrandiKamenar.com
Email: [email protected]
Phone: (310) 734-6180
SOURCE: Lanman Spinal Neurosurgery
View the original press release on ACCESS Newswire
D.Johnson--AT